Joshua Bonkowsky, MD, PhD: Pediatric neurology and laboratory models of leukodystrophy

By The Lucas Project

Joshua Bonkowsky is a University of Utah physician-scientist whose work includes childhood leukodystrophies. His laboratory studies disease biology using experimental models, alongside broader efforts to understand neurological development. University research profile

Specialty and research focus

Bonkowsky’s work includes experimental models of neurological disease. These help researchers investigate mechanisms and generate ideas for further testing. A result in a model organism is not proof of safety or benefit in people. University research profile Dedicated laboratory giving page

What the 2017 zebrafish study contributed

In a 2017 study, Bonkowsky and colleagues described a zebrafish model of X-linked adrenoleukodystrophy (ALD) that reproduced several disease features. The work examined the role of abcd1 in cells involved in myelin formation and provided an experimental system for studying disease biology. 2017 study

A model is useful because researchers can investigate processes that are difficult to study directly in people. It also has limitations: a fish does not reproduce every feature of human disease. A finding in this system needs further investigation before it can support a claim about a treatment for families.

The historical paper establishes this contribution. It does not, by itself, verify that the lab is currently screening ALD drugs, recruiting patients for an ALD trial or offering a therapy. The University of Utah describes a wider laboratory program involving neurological development and leukodystrophies. University laboratory overview

How to contact the team

The university lists joshua.bonkowsky@hsc.utah.edu as a professional contact. This is a research inquiry route, not a verified appointment-booking inbox. University research profile

How to support the work

Utah has a dedicated Bonkowsky Lab – Research Studies of Leukodystrophy giving page. It supports leukodystrophy research in the lab; the page does not establish that every gift is restricted to ALD. Ask about designation if that distinction matters to your donation. Dedicated laboratory giving page

Questions for the laboratory or giving team

Ask which leukodystrophy projects are active and whether a proposed donation can be designated specifically for ALD. For a research inquiry, ask whether the lab is the appropriate contact or whether a clinical program should handle it. Confirm participation opportunities directly rather than inferring them from an older paper.

Professional contacts and giving designations were checked on November 11, 2026; confirm them with the institution before making arrangements.

Previous
Previous

Meet the People Working in ALD Care and Research

Next
Next

Molly O. Regelmann, MD: Pediatric endocrinology and adrenal care in ALD